AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26156512 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise protein-carbohydrate supplementation
Number of subjects: 61
Study 22928719 — intervention group
Group type: EXPERIMENTAL
Intervention: Miltefosine (150 mg daily for 4 weeks)
Number of subjects: 73
Study 22928719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 22928719 — intervention group
Group type: EXPERIMENTAL
Intervention: Miltefosine
Number of subjects: 73
Study 20216222 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (400, 600 or 800 mg/day)
Number of subjects: 197
Study 20216222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 20216222 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 197
Study 18820779 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 40
Study 18820779 — intervention group
Group type: COMPARATOR
Intervention: No ultrafiltration (Control)
Number of subjects: 40
Study 18820779 — intervention group
Group type: COMPARATOR
Intervention: Ultrafiltration and No ultrafiltration (Control)
Number of subjects: 40
Study 17682259 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 921
Study 17682259 — intervention group
Group type: COMPARATOR
Intervention: Social support
Number of subjects: 921
Study 17682259 — intervention group
Group type: COMPARATOR
Intervention: Self-reported feelings of anger
Number of subjects: 921
Study 14666762 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Compound Changjitai (CJT)
Number of subjects: 45
Study 14666762 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium bromide (PVB)
Number of subjects: 45
Study 10713623 — intervention group
Group type: EXPERIMENTAL
Intervention: MEL-CY (cyclophosphamide 120 mg/kg + melphalan 200 mg/m2)
Number of subjects: 43
Study 10713623 — intervention group
Group type: EXPERIMENTAL
Intervention: MEL-TBI (total body irradiation 1125 cGy + melphalan 140 mg/m2)
Number of subjects: 43
Study 10713623 — intervention group
Group type: COMPARATOR
Intervention: MEL200 (melphalan alone)
Number of subjects: 43
Study 8693374 — intervention group
Group type: EXPERIMENTAL
Intervention: Current viral infection in children with pneumonia
Number of subjects: 48
Study 8693374 — intervention group
Group type: EXPERIMENTAL
Intervention: Overcrowding in homes
Number of subjects: 48
Study 8693374 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupancy of the room where the child slept
Number of subjects: 48
Study 8693374 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic smoke pollution
Number of subjects: 48
Study 8693374 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status
Number of subjects: 48
Study 8693374 — intervention group
Group type: COMPARATOR
Intervention: Recurrence of respiratory symptoms
Number of subjects: 48
Study 8693374 — intervention group
Group type: COMPARATOR
Intervention: Need to visit a health facility
Number of subjects: 48
Study 1497051 — intervention group
Group type: EXPERIMENTAL
Intervention: Esterified estrogen 0.625 mg (Estratab)
Number of subjects: 17
Study 1497051 — intervention group
Group type: EXPERIMENTAL
Intervention: Esterified estrogen 0.625 mg plus 1.25 mg methyltestosterone (Estratest H.S.)
Number of subjects: 17
Study 1497051 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogen 0.625 mg (Premarin)
Number of subjects: 17
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 500 mg of salicylamide
Number of subjects: 0
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of 500 mg of salicylamide
Number of subjects: 0
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 1500 mg of salicylamide
Number of subjects: 0
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of 1500 mg of salicylamide
Number of subjects: 0
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of salicylamide
Number of subjects: 0
Study 6689276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of salicylamide
Number of subjects: 0
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful VBAC
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the four intrapartum interventions (amniotomy, oxytocin, epidural, opioids)
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier performance of amniotomy (ARM)
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous vaginal birth
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer labour duration
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher infant birthweight
Number of subjects: 790
Study 30925415 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy (ARM)
Number of subjects: 790
Study 30373547 — intervention group
Group type: EXPERIMENTAL
Intervention: TRD patients
Number of subjects: 2467
Study 30373547 — intervention group
Group type: COMPARATOR
Intervention: non-TRD patients
Number of subjects: 2467
Study 26851494 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 67
Study 26851494 — intervention group
Group type: COMPARATOR
Intervention: Health education intervention
Number of subjects: 67
Study 26851494 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment (EMA)
Number of subjects: 67
Study 26851494 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil measures
Number of subjects: 67
Study 24707022 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Interaction Project (VIP)
Number of subjects: 407
Study 22584017 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral prednisone (6.25 mg/day) co-medication with methotrexate (MTX)
Number of subjects: 220
Study 22584017 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 220
Study 20350619 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAMcare intervention
Number of subjects: 0
Study 17408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue Only (lean towards beverage)
Number of subjects: 188
Study 17408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue+Action (lift beverage towards them)
Number of subjects: 188
Study 17408866 — intervention group
Group type: COMPARATOR
Intervention: Overall
Number of subjects: 188
Study 16035056 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60-mg QD
Number of subjects: 512
Study 16035056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 512
Study 12010529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing-led intermediate care in-patient units (NLIU)
Number of subjects: 177
Study 12010529 — intervention group
Group type: COMPARATOR
Intervention: Control wards (16 wards referring patients to NLIU)
Number of subjects: 177
Study 10534515 — intervention group
Group type: EXPERIMENTAL
Intervention: Clexane (enoxaparin sodium) 1 mg/kg body weight
Number of subjects: 36
Study 10534515 — intervention group
Group type: EXPERIMENTAL
Intervention: Clexane (enoxaparin sodium) 0.69 mg/kg (after dose reduction)
Number of subjects: 36
Study 10534515 — intervention group
Group type: COMPARATOR
Intervention: Standard unfractionated heparin
Number of subjects: 36
Study 7781662 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril treatment on high sodium diet
Number of subjects: 8
Study 7781662 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril treatment on low sodium diet
Number of subjects: 8
Study 7781662 — intervention group
Group type: COMPARATOR
Intervention: Control (low sodium diet without candoxatril)
Number of subjects: 8
Study 7781662 — intervention group
Group type: COMPARATOR
Intervention: Control (high sodium diet without candoxatril)
Number of subjects: 8
Study 2191189 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intraperitoneal insulin (CIPII)
Number of subjects: 5
Study 2191189 — intervention group
Group type: COMPARATOR
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 5
Study 7007260 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 35
Study 7007260 — intervention group
Group type: COMPARATOR
Intervention: Control (blind control manner)
Number of subjects: 35
Study 31662328 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus 72 hours of hypothermia (33.5°C±0.5°C, n=25)
Number of subjects: 50
Study 31662328 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=25)
Number of subjects: 50
Study 31045840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 2×ED95 (0.182 mg/kg)
Number of subjects: 148
Study 31045840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone ED95 (0.091 mg/kg)
Number of subjects: 148
Study 31045840 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 μg/kg
Number of subjects: 148
Study 31045840 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 148
Study 31045840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 0.269 mg/kg (recalculated ED95)
Number of subjects: 148
Study 28671089 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% liranaftate ointment
Number of subjects: 1100
Study 28671089 — intervention group
Group type: COMPARATOR
Intervention: 1% bifonazole cream
Number of subjects: 1100
Study 25884300 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based health worker led case management approach
Number of subjects: 213
Study 25884300 — intervention group
Group type: COMPARATOR
Intervention: Usual care (waitlist control group)
Number of subjects: 213
Study 23478248 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 600 mg plus three-drug regimen (pantoprazole 40 mg BD, ciprofloxacin 500 mg BD, bismuth subcitrate 120 mg two tablets BD)
Number of subjects: 60
Study 23478248 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus three-drug regimen (pantoprazole 40 mg BD, ciprofloxacin 500 mg BD, bismuth subcitrate 120 mg two tablets BD)
Number of subjects: 60
Study 23478248 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 60
Study 20546968 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and Carboplatin (GC)
Number of subjects: 123
Study 20546968 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine, Carboplatin, and Docetaxel (GCD)
Number of subjects: 123
Study 19573904 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate (0.3 mg/kg)
Number of subjects: 655
Study 19573904 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (2 mg/kg)
Number of subjects: 655
Study 19573904 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 655
Study 19573904 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 655
Study 17449250 — intervention group
Group type: EXPERIMENTAL
Intervention: erbB2+ cluster
Number of subjects: 50
Study 17449250 — intervention group
Group type: COMPARATOR
Intervention: normal-like cluster
Number of subjects: 50
Study 17449250 — intervention group
Group type: COMPARATOR
Intervention: basal-like cluster
Number of subjects: 50
Study 17449250 — intervention group
Group type: COMPARATOR
Intervention: luminal cluster
Number of subjects: 50
Study 15386160 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU vitamin D3 plus 1 g calcium
Number of subjects: 30
Study 15386160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11318022 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam ear plugs under headset
Number of subjects: 9
Study 11318022 — intervention group
Group type: EXPERIMENTAL
Intervention: Hi-fi plugs under headset
Number of subjects: 9
Study 11318022 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom made ear plugs under headset
Number of subjects: 9
Study 11318022 — intervention group
Group type: COMPARATOR
Intervention: Headset only
Number of subjects: 9
Study 9044475 — intervention group
Group type: EXPERIMENTAL
Intervention: rt‐PA plus heparin (H) (n = 10)
Number of subjects: 20
Study 9044475 — intervention group
Group type: COMPARATOR
Intervention: Heparin (H) alone (n = 10)
Number of subjects: 20
Study 8196289 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg losartan
Number of subjects: 11
Study 8196289 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg enalapril
Number of subjects: 11
Study 8196289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3630891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin pretreatment (3.6 mg/kg lysine salt of acetylsalicylic acid, corresponding to 2 mg/kg aspirin)
Number of subjects: 14
Study 3630891 — intervention group
Group type: COMPARATOR
Intervention: No aspirin pretreatment
Number of subjects: 14
Study 3630891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin pretreatment
Number of subjects: 14
Study 30870252 — intervention group
Group type: EXPERIMENTAL
Intervention: cherry extract
Number of subjects: 84
Study 30870252 — intervention group
Group type: COMPARATOR
Intervention: dietitian-assisted diet modification
Number of subjects: 84
Study 30870252 — intervention group
Group type: COMPARATOR
Intervention: diet modification
Number of subjects: 84
Study 29157789 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phones in 'on' mode for 15 minutes (exposed to 900-1800MHz EMW)
Number of subjects: 30
Study 29157789 — intervention group
Group type: COMPARATOR
Intervention: Mobile phones in 'off' mode for 15 minutes
Number of subjects: 30
Study 26725548 — intervention group
Group type: EXPERIMENTAL
Intervention: Chant Talk
Number of subjects: 40
Study 26725548 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch Inflections
Number of subjects: 40
Study 26725548 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 24821586 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin 5mg daily
Number of subjects: 2701
Study 24821586 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2701
Study 22552566 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg a day
Number of subjects: 25620
Study 22552566 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg a day
Number of subjects: 25620
Study 22552566 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ramipril 10 mg + telmisartan 80 mg)
Number of subjects: 25620
Study 20084279 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs associated with CIN3/cancer: OAS3 rs12302655, SULF1 rs4737999, IFNG rs11177074, DUT rs3784621, DMC1 rs5757133, GTF2H4 rs2894054, EVER1/EVER2 rs9893818
Number of subjects: 1167
Study 20084279 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs for OAS3, SULF1, DUT, and GTF2H4
Number of subjects: 1167
Study 20084279 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNG and EVER1/EVER2 SNPs
Number of subjects: 1167
Study 20084279 — intervention group
Group type: COMPARATOR
Intervention: Control group (random controls)
Number of subjects: 1167
Study 18711936 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (prednisolone 40 mg daily tapered to 5 mg over 12 weeks) + MB-MDT
Number of subjects: 400
Study 18711936 — intervention group
Group type: COMPARATOR
Intervention: MB-MDT only
Number of subjects: 400
Study 17045906 — intervention group
Group type: COMPARATOR
Intervention: Inhaled treprostinil at 7.5 mug
Number of subjects: 123
Study 17045906 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil at 30 mug
Number of subjects: 123
Study 17045906 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil at 15 mug with varying pulses (18, 9, 3, 2, 1)
Number of subjects: 123
Study 14530421 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-spaced elastomeric chain
Number of subjects: 22
Study 14530421 — intervention group
Group type: EXPERIMENTAL
Intervention: Nickel titanium coil springs
Number of subjects: 22
Study 10894582 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (20‐120 mg) and fentanyl (0.25‐1.5 mg)
Number of subjects: 274
Study 10894582 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (2‐6 mg) and meperidine (25‐75 mg)
Number of subjects: 274
Study 8667091 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician communication intervention (4.5 hours of training on eliciting and responding to patients' concerns)
Number of subjects: 348
Study 8667091 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician communication intervention
Number of subjects: 348
Study 8667091 — intervention group
Group type: COMPARATOR
Intervention: Control group (4.5 hours of training in medical decision-making)
Number of subjects: 348
Study 1545092 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal elimination diet (abstaining from cow's milk and egg from gestational week 28 to delivery)
Number of subjects: 198
Study 1545092 — intervention group
Group type: COMPARATOR
Intervention: Normal food during pregnancy (control group)
Number of subjects: 198
Study 1545092 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal elimination diet
Number of subjects: 198
Study 3904410 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine detoxification
Number of subjects: 39
Study 3904410 — intervention group
Group type: COMPARATOR
Intervention: Slow tapering of methadone
Number of subjects: 39
Study 31985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with mean arterial blood pressure (MABP) less than 70 mm Hg for a minimum of 10 minutes
Number of subjects: 365
Study 31985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with mean arterial blood pressure (MABP) less than 70 mm Hg for a continuous episode of minimum 20 minutes
Number of subjects: 365
Study 31985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with mean arterial blood pressure (MABP) greater than 90 mm Hg for a minimum of 45 minutes
Number of subjects: 365
Study 31985746 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with mean arterial blood pressure (MABP) greater than 90 mm Hg for a continuous episode of minimum 115 minutes
Number of subjects: 365
Study 28971973 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus rehabilitation (3-month multimodal hybrid inpatient-outpatient motivation, exercise and nutrition rehabilitation programme, in addition to non-invasive ventilation)
Number of subjects: 37
Study 28971973 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 37
Study 27234601 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograph-enhanced discharge instructions
Number of subjects: 144
Study 27234601 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge instructions
Number of subjects: 144
Study 24872027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine oral spray (1mg of nicotine free base per spray) plus nicotine patch
Number of subjects: 1423
Study 24872027 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray plus nicotine patch
Number of subjects: 1423
Study 23649050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg every 8 hours for 3 days
Number of subjects: 110
Study 23649050 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratiopaptidase 10 mg every 8 hours for 3 days
Number of subjects: 110
Study 20819867 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tasks with interruptions
Number of subjects: 32
Study 20819867 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple tasks with interruptions
Number of subjects: 32
Study 20819867 — intervention group
Group type: COMPARATOR
Intervention: All prescribing tasks
Number of subjects: 32
Study 18524271 — intervention group
Group type: EXPERIMENTAL
Intervention: Formocresol pulpotomy
Number of subjects: 50
Study 18524271 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 50
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-progestin replacement therapy
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogens alone
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT cessation
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal dose of estrogens
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT indication
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-sonography
Number of subjects: 0
Study 15828615 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast surveillance
Number of subjects: 0
Study 12461301 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone, 12.5-25 mg/d (n=15,255)
Number of subjects: 33357
Study 12461301 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine, 2.5-10 mg/d (n=9048)
Number of subjects: 33357
Study 12461301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril, 10-40 mg/d (n=9054)
Number of subjects: 33357
Study 12461301 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups combined)
Number of subjects: 33357
Study 10492100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive regimen (3000 microg dinoprostone given three times daily)
Number of subjects: 100
Study 10492100 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (3000 microg dinoprostone once daily)
Number of subjects: 100
Study 10492100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive regimen
Number of subjects: 100
Study 10492100 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen
Number of subjects: 100
Study 10492100 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 100
Study 8758286 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral artemether (Art) 6 mg/kg followed by 3 repeated doses every 15 days
Number of subjects: 741
Study 8758286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 741
Study 1861474 — intervention group
Group type: EXPERIMENTAL
Intervention: Type B music (soft, slow, easy-listening, popular music)
Number of subjects: 24
Study 1861474 — intervention group
Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 24
Study 1861474 — intervention group
Group type: EXPERIMENTAL
Intervention: Type A music (loud, fast, exciting, popular music)
Number of subjects: 24